Australian army faces legal action over mefloquineBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7474.1062-b (Published 04 November 2004) Cite this as: BMJ 2004;329:1062
- Bob Burton
The Australian army and Roche Products Australia face a class action after allegations that army personnel had serious side effects after being prescribed mefloquine hydrochloride (Lariam) as part of a research trial for a new anti-malarial drug.
Since 1998, the Army Malaria Institute, a research organisation of the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial